Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04935957
Other study ID # DIA-2021-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 11, 2024
Est. completion date May 2024

Study information

Verified date March 2024
Source iGluco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a prospective, single center, non-interventional, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE system compared to the standard glucometer in the determination of blood glucose level in adult patients.


Description:

The current methods for blood glucose measurements, glucometers, although minimally invasive, can be painful, requiring puncturing the fingertip with a lancet device and removing a drop of blood, that applies to a disposable test strip. This minimal invasiveness may cause discomfort and deter the user from measuring his/her blood glucose levels as frequently as required. Due to GLUCUBE device non-invasive nature, it is expected to give the patient or health care provider immediate reliable quantitative as well as qualitative information, safely and painlessly avoiding any type of discomfort to the user. This study is a prospective, single center, non-interventional, open label clinical investigation designed with a total amount of 105 subjects. Study participants will take the GLUCUBE device and standard glucometer home and each subject will take 4 pairs of measurements per day for a week.


Recruitment information / eligibility

Status Recruiting
Enrollment 105
Est. completion date May 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Be = 18 years old. 2. Have a smartphone with an internet connection that allows the installation of GLUCUBE APP 3. Have signed the informed consent. Exclusion Criteria: 1. Subject is currently participating in another clinical investigation or has participated in another clinical investigation in the past 30 days prior to the start of the present study. 2. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period. 3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results. 4. Patients with any acute active and/or infectious disease. 5. Patients who have a condition that affects blood circulation in the fingers of the hand, such as Raynaud's phenomenon. 6. Any medical condition that, by the investigator judgment, will increase the risk from hyper and hypoglycemic event: seizures, heart disease, hypoglycemia unawareness, etc. 7. Patients who, in the opinion of the investigator, do not have sufficient manual dexterity to perform the tests themselves. 8. Patients with an inability to maintain stability of the hand during measurement or with progressive disease of the nervous system that affects movement (Parkinson's disease, moderate-severe essential tremor, and other diseases with involuntary movements). 9. Patients suffering from calluses, malformations, or open wounds with bandages. 10. Patients with nail polish or any type of false nail. 11. Subjects who do not understand or cannot follow the Procedures Involved in the Use of the Device Under Investigation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
GLUCUBE device
device to monitor and measure the blood glucose compared to the standard glucometer in a group subjects

Locations

Country Name City State
Spain Centro de Salud La Algaba La Algaba Sevilla

Sponsors (1)

Lead Sponsor Collaborator
iGluco

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other User satisfaction Patient reported satisfaction related to the investigational device: in a 1 to 10 scale: 1 - Disagree, 10 - Agree.
And, if given the choice, will you use GLUCUBE device again? Yes or No
8 days after the participant enters the study
Primary Performance Evaluation GLUCUBE system performance in the monitoring and measurement of the blood glucose compared to the standard glucometer (blood capillary glucometer - Bayer Contour®Next).
Each pair of measurements includes one measurement with the standard glucometer (Bayer Contour®Next) and one measurement with GLUCUBE device.
4 times/day for 1 week
Primary Safety Evaluation All (Serious) Adverse Events and GLUCUBE device related adverse events: local and systemic effects of GLUCUBE device, and the standard glucometer, including, but not limited to redness, burns, pain, or other complications such as bleeding or local infection will be collected. All AE will be collected during participation in the study since V1 at V2 (8 days)
Secondary Performance Evaluation GLUCUBE system performance in the monitoring and measurement of the blood glucose compared to the standardized POC device for the determination of glucose (Accu-Chek® Inform II system).
Each pair of measurements includes one measurement with standardized POC device for the determination of glucose (Accu-Chek® Inform II system) and one measurement with GLUCUBE device.
through study completion, an average of 8 days
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT04256746 - Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose N/A
Completed NCT03254082 - Glycemic Response of Sorghum N/A
Completed NCT02536066 - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose N/A
Completed NCT00444171 - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients N/A
Completed NCT00302302 - The Effects of L-arabinose on Intestinal Sucrase Activity in Man Phase 1
Completed NCT04378374 - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake N/A
Completed NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery N/A
Recruiting NCT04989712 - MOReS Freestyle Libre Validation Study N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04260425 - A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response N/A
Completed NCT04258501 - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response N/A
Completed NCT02968498 - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers N/A
Completed NCT02484313 - The Effect of Snacks on Glycaemic Regulation in Children N/A
Withdrawn NCT01246492 - The Effect of Artificial Sweeteners on Blood Glucose Response N/A
Completed NCT01241253 - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Phase 2
Completed NCT03914430 - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake N/A
Recruiting NCT05255783 - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients N/A
Completed NCT05573607 - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life N/A
Recruiting NCT05585801 - Continuous Glucose Monitoring in Intensive Care Unit N/A